Peti Thuwajit

About Peti Thuwajit

Peti Thuwajit, With an exceptional h-index of 23 and a recent h-index of 17 (since 2020), a distinguished researcher at Mahidol University, specializes in the field of Cancer Immunology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Mesothelin-and nucleolin-specific T cells from combined short peptides effectively kill triple-negative breast cancer cells

Cytotoxicity of fourth-generation anti-Trop2 CAR-T cells against breast cancer

Hippo pathway in cancer cells modulates tumor microenvironment by inducing immunosuppressive NCAM1+ αSMA+ fibroblasts

Stimulating T cell responses against patient-derived breast cancer cells with neoantigen peptide-loaded peripheral blood mononuclear cells

Detection of centroblast cells in H&E stained whole slide image based on object detection

Nucleolin‑based targeting strategies in cancer treatment: Focus on cancer immunotherapy

Enhancement of PD-L1-attenuated CAR-T cell function through breast cancer-associated fibroblasts-derived IL-6 signaling via STAT3/AKT pathways

Novel CSF1R-positive tenosynovial giant cell tumor cell lines and their pexidartinib (PLX3397) and sotuletinib (BLZ945)-induced apoptosis

Peti Thuwajit Information

University

Position

Departmeny of Immunology Faculty of Medicine Siriraj Hospital

Citations(all)

3536

Citations(since 2020)

2029

Cited By

2533

hIndex(all)

23

hIndex(since 2020)

17

i10Index(all)

34

i10Index(since 2020)

27

Email

University Profile Page

Google Scholar

Peti Thuwajit Skills & Research Interests

Cancer Immunology

Top articles of Peti Thuwajit

Mesothelin-and nucleolin-specific T cells from combined short peptides effectively kill triple-negative breast cancer cells

2024/4/29

Cytotoxicity of fourth-generation anti-Trop2 CAR-T cells against breast cancer

International Immunopharmacology

2024/3/10

Peti Thuwajit
Peti Thuwajit

H-Index: 16

Hippo pathway in cancer cells modulates tumor microenvironment by inducing immunosuppressive NCAM1+ αSMA+ fibroblasts

2024/2/16

Stimulating T cell responses against patient-derived breast cancer cells with neoantigen peptide-loaded peripheral blood mononuclear cells

Cancer Immunology, Immunotherapy

2024/2/13

Detection of centroblast cells in H&E stained whole slide image based on object detection

Frontiers in Medicine

2024/2/7

Nucleolin‑based targeting strategies in cancer treatment: Focus on cancer immunotherapy

2023/9/1

Peti Thuwajit
Peti Thuwajit

H-Index: 16

Chanitra Thuwajit
Chanitra Thuwajit

H-Index: 15

Enhancement of PD-L1-attenuated CAR-T cell function through breast cancer-associated fibroblasts-derived IL-6 signaling via STAT3/AKT pathways

Breast Cancer Research

2023/7/21

Peti Thuwajit
Peti Thuwajit

H-Index: 16

Chanitra Thuwajit
Chanitra Thuwajit

H-Index: 15

Novel CSF1R-positive tenosynovial giant cell tumor cell lines and their pexidartinib (PLX3397) and sotuletinib (BLZ945)-induced apoptosis

Human Cell

2023/1

Peti Thuwajit
Peti Thuwajit

H-Index: 16

Chanitra Thuwajit
Chanitra Thuwajit

H-Index: 15

Cellular localization of nucleolin determines the prognosis in cancers: a meta-analysis

2022/8

Mesothelin‑specific T cell cytotoxicity against triple negative breast cancer is enhanced by 40s ribosomal protein subunit 3‑treated self‑differentiated dendritic cells

Oncology Reports

2022/7/1

HMGB1 mediates invasion and PD-L1 expression through RAGE-PI3K/AKT signaling pathway in MDA-MB-231 breast cancer cells

BMC cancer

2022/5/24

Peti Thuwajit
Peti Thuwajit

H-Index: 16

Chanitra Thuwajit
Chanitra Thuwajit

H-Index: 15

Adoptive transfer of anti-nucleolin T cells combined with PD-L1 inhibition against triple-negative breast cancer

Molecular Cancer Therapeutics

2022/5/4

Diagnostic power of DNA methylation markers suggestive of cholangiocarcinoma in ERCP-based brush cytology

Gastrointestinal Endoscopy

2022/1/1

Establishment and characterization of novel highly aggressive HER2‑positive and triple‑negative breast cancer cell lines

Oncology Reports

2021/12/1

Peti Thuwajit
Peti Thuwajit

H-Index: 16

Chanitra Thuwajit
Chanitra Thuwajit

H-Index: 15

Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancer

BMC cancer

2021/12

Intracellular IL-33 attenuates extracellular IL-33-induced cholangiocarcinoma cell proliferation and invasion via NF-κB and GSK-3β pathways

Anticancer Research

2021/10/1

Crosstalk between tumor-infiltrating immune cells and cancer-associated fibroblasts in tumor growth and immunosuppression of breast cancer

2021/7/13

Peti Thuwajit
Peti Thuwajit

H-Index: 16

Chanitra Thuwajit
Chanitra Thuwajit

H-Index: 15

Interleukin‑8 released by cancer‑associated fibroblasts attenuates the autophagy and promotes the migration of ovarian cancer cells

International Journal of Oncology

2021/5/1

Peti Thuwajit
Peti Thuwajit

H-Index: 16

Chanitra Thuwajit
Chanitra Thuwajit

H-Index: 15

Breast cancer stem cell RNA‑pulsed dendritic cells enhance tumor cell killing by effector T cells

Oncology Letters

2020/3/1

High level of interleukin-33 in cancer cells and cancer-associated fibroblasts correlates with good prognosis and suppressed migration in cholangiocarcinoma

Journal of Cancer

2020

See List of Professors in Peti Thuwajit University(Mahidol University)